Diabetes Screening & Prediabetes

One in three American adults has prediabetes and most do not know it. The community health nurse who screens them today prevents the diabetic foot wound five years from now.

Diabetes screening in the community targets asymptomatic adults to detect prediabetes and type 2 diabetes early, when lifestyle interventions are most effective. The USPSTF recommends screening for adults aged 35-70 who are overweight or obese. The ADA recommends screening for all adults starting at age 35 (previously 45), and earlier for those with risk factors: BMI 25 or higher (23 or higher for Asian Americans), family history of diabetes, history of gestational diabetes, polycystic ovary syndrome, race/ethnicity with higher prevalence (Black, Hispanic, Native American, Asian American, Pacific Islander), hypertension, HDL under 35 or triglycerides over 250, or physical inactivity. Three screening tests are used: fasting plasma glucose (FPG), oral glucose tolerance test (OGTT), and hemoglobin A1C. Prediabetes is defined as FPG 100-125, OGTT 140-199, or A1C 5.7-6.4%. Diabetes is diagnosed at FPG 126 or higher, OGTT 200 or higher, or A1C 6.5% or higher. Two abnormal results from the same or different tests are required for diagnosis in asymptomatic individuals. The community health nurse's role includes identifying at-risk individuals through risk assessment questionnaires, conducting or facilitating screening at community sites, educating on the Diabetes Prevention Program (DPP) — an evidence-based lifestyle intervention shown to reduce diabetes risk by 58% through modest weight loss (5-7% of body weight) and 150 minutes per week of moderate physical activity. The nurse refers individuals with abnormal results to primary care and provides culturally appropriate dietary education emphasizing whole grains, vegetables, lean proteins, and portion control.

Key Distinctions

Prediabetes is NOT diabetes — it is a reversible state. The community nurse's message to a prediabetic client is empowerment (you can prevent this), not resignation (you are going to develop diabetes). Students confuse A1C with fasting glucose — A1C reflects average glucose over 2-3 months and does not require fasting, making it convenient for community screening events where fasting cannot be guaranteed. However, FPG, A1C, and OGTT are all accepted screening tests per USPSTF; none is universally preferred. Point-of-care A1C results are useful for screening, but abnormal findings generally require laboratory confirmation before diagnosis. The DPP is a structured lifestyle program, not generic advice to 'eat better and exercise.' Gestational diabetes is a risk factor for future type 2 diabetes — women with a history of GDM should be screened every 1-3 years postpartum.

Clinical Pearl

A1C does not require fasting — that makes it convenient for community events where participants walk in unprepared. One finger stick, no special preparation, and you have three months of glucose history. But remember: FPG and OGTT are equally valid screening options, and abnormal point-of-care results need lab confirmation.